Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
暂无分享,去创建一个
O. Boyman | F. Nestle | Yong‐jun Liu | G. Burg | M. Gilliet | C. Conrad | B. Homey | M. Gombert | A. Tun-Kyi | Yong‐jun Liu
[1] K. Honda,et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.
[2] I. Elefsiniotis,et al. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. , 2005, European journal of dermatology : EJD.
[3] S. Akira,et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease , 2005, Nature Medicine.
[4] B. Beutler,et al. TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .
[5] Yong‐jun Liu,et al. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.
[6] R. Dummer,et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. , 2004, Archives of dermatology.
[7] J. Krueger,et al. Current concepts in the immunopathogenesis of psoriasis. , 2004, Dermatologic clinics.
[8] C. Coban,et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.
[9] E. Coccia,et al. Characterization and Recruitment of Plasmacytoid Dendritic Cells in Synovial Fluid and Tissue of Patients with Chronic Inflammatory Arthritis1 , 2004, The Journal of Immunology.
[10] J. Saurat,et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference , 2004, The British journal of dermatology.
[11] F. Nestle,et al. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.
[12] A. Bowcock,et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.
[13] V. Pascual,et al. Autoimmunity through cytokine-induced dendritic cell activation. , 2004, Immunity.
[14] P. V. D. van de Kerkhof,et al. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late , 2004, The British journal of dermatology.
[15] Khusru Asadullah,et al. Biology of tumor necrosis factor‐α– implications for psoriasis , 2004, Experimental dermatology.
[16] M. Matyszak,et al. Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. , 2004, Rheumatology.
[17] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[18] A. Bowcock,et al. Interferon α-Inducible Protein 27 (IFI27) is Upregulated in Psoriatic Skin and Certain Epithelial Cancers , 2004 .
[19] T. Kupper,et al. Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.
[20] Frank O. Nestle,et al. Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α , 2004, The Journal of experimental medicine.
[21] L. van der Fits,et al. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered. , 2004, The Journal of investigative dermatology.
[22] L. Calabrese,et al. Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α , 2003, Autoimmunity.
[23] T. Kopp,et al. Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? , 2003, The Journal of investigative dermatology.
[24] A. Gottlieb,et al. Etanercept as monotherapy in patients with psoriasis. , 2003, The New England journal of medicine.
[25] P. Borrow,et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.
[26] R. Kastelein,et al. IL-27 and IFN-α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells , 2003 .
[27] Christophe Caux,et al. The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12 , 2003, The Journal of experimental medicine.
[28] M. Gilliet,et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. , 2003, Blood.
[29] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[30] R. de Waal Malefyt,et al. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[31] G. Hartmann,et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. , 2002, The Journal of investigative dermatology.
[32] Antonio Lanzavecchia,et al. BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.
[33] Virginia Pascual,et al. Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.
[34] Antonio Lanzavecchia,et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.
[35] N. Kadowaki,et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.
[36] F. Lund-Johansen,et al. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.
[37] U. Chaudhari,et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial , 2001, The Lancet.
[38] V. Pascual,et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.
[39] D. Lemaire,et al. Rheumatoid arthritis induced by alpha-interferon therapy. , 2001, Clinical rheumatology.
[40] T. Taniguchi,et al. CD8 (+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling , 2000 .
[41] G. Sturfelt,et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.
[42] T. Taniguchi,et al. Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction , 2000 .
[43] F. Lund-Johansen,et al. Experimentally Induced Recruitment of Plasmacytoid (CD123high) Dendritic Cells in Human Nasal Allergy1 , 2000, The Journal of Immunology.
[44] N. Kadowaki,et al. Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity , 2000, The Journal of experimental medicine.
[45] J. Hawk. Cryotherapy may be effective for eyelid xanthelasma , 2000, Clinical and experimental dermatology.
[46] A. Downs,et al. Exacerbation of psoriasis by interferon‐alpha therapy for hepatitis C , 2000, Clinical and experimental dermatology.
[47] T. Taniguchi,et al. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. , 2000, Immunity.
[48] T. Taniguchi,et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. , 2000, Immunity.
[49] B. Diamond,et al. Autoimmune diseases , 2000, Bone Marrow Transplantation.
[50] L. Rönnblom,et al. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. , 1999, Journal of immunology.
[51] D. Jarrossay,et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.
[52] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[53] L. Rönnblom,et al. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. , 1998, Journal of autoimmunity.
[54] J. Sprent,et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.
[55] L. Adorini,et al. Pathogenesis and immunotherapy of autoimmune diseases. , 1997, Immunology today.
[56] J. Banchereau,et al. The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand , 1997, The Journal of experimental medicine.
[57] J. Voorhees,et al. Psoriasis, T Cells and Autoimmunity , 1996, Journal of the Royal Society of Medicine.
[58] K. D. Zylan,et al. Article , 1996, Physiology & Behavior.
[59] Kristina J. Liu,et al. Report of two cases , 1995 .
[60] J. Pavlovic,et al. Expression of MxA protein in inflammatory dermatoses. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[61] Å. Lernmark,et al. Interferon Expression in the Pancreases of Patients With Type I Diabetes , 1995, Diabetes.
[62] P. Itin,et al. The type I interferon system is locally activated in psoriatic lesions. , 1994, Journal of interferon research.
[63] F. Nestle,et al. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. , 1994, The Journal of clinical investigation.
[64] C. Levy-marchal,et al. Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia , 1994, The Lancet.
[65] H. Hochkeppel,et al. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. , 1994, The Journal of infectious diseases.
[66] G. Pozzato,et al. Psoriasis exacerbation induced by interferon-alpha. Report of two cases. , 1993, Acta dermato-venereologica.
[67] Xiaojian Huang,et al. Induction of type I diabetes by interferon-alpha in transgenic mice. , 1993, Science.
[68] O. Colamonici,et al. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. , 1993, The Journal of biological chemistry.
[69] K. Melén,et al. Control of IFN-inducible MxA gene expression in human cells. , 1993, Journal of immunology.
[70] E. Schrumpf,et al. Psoriasis induced by interferon‐α , 1991 .
[71] E. Schrumpf,et al. Psoriasis induced by interferon-alpha. , 1991, The British journal of dermatology.
[72] I. Mackay,et al. Autoimmune diseases. , 1981, Scientific American.